BRETYLIUM TOSYLATE IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
When do Bretylium Tosylate In Dextrose 5% patents expire, and what generic alternatives are available?
Bretylium Tosylate In Dextrose 5% is a drug marketed by Abbott, B Braun, Baxter Hlthcare, and Hospira Inc. and is included in four NDAs.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRETYLIUM TOSYLATE IN DEXTROSE 5%?
- What are the global sales for BRETYLIUM TOSYLATE IN DEXTROSE 5%?
- What is Average Wholesale Price for BRETYLIUM TOSYLATE IN DEXTROSE 5%?
Summary for BRETYLIUM TOSYLATE IN DEXTROSE 5%
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
DailyMed Link: | BRETYLIUM TOSYLATE IN DEXTROSE 5% at DailyMed |
![BRETYLIUM TOSYLATE IN DEXTROSE 5% drug patent expirations Drug patent expirations by year for BRETYLIUM TOSYLATE IN DEXTROSE 5%](/p/graph/s/t/BRETYLIUM_TOSYLATE_IN_DEXTROSE_5%-patent-expirations.png)